🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 08659B102
- IPO
- 1/30/2025 · $18.00/share
Business: Beta Bionics, Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of insulin-requiring people with diabetes.
Company Contact
- CEO
- Sean Saint
- CFO
- Stephen Feider
- Headquarters
- 11 Hughes, Irvine, CA 92618
- Phone
- 949-427-7785
- Investor Relations
- Blake Beber · 949-427-7785 · ir@betabionics.com